AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$392M |
| 2 |
Qualcomm
QCOM
|
+$262M |
| 3 |
Microsoft
MSFT
|
+$260M |
| 4 |
Illumina
ILMN
|
+$259M |
| 5 |
International Flavors & Fragrances
IFF
|
+$248M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$341M |
| 2 |
Biogen
BIIB
|
+$295M |
| 3 |
Apple
AAPL
|
+$289M |
| 4 |
Booking.com
BKNG
|
+$207M |
| 5 |
CELG
Celgene Corp
CELG
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.43% |
| 2 | Healthcare | 15.41% |
| 3 | Financials | 15.33% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FEDU
2301
Four Seasons Education Depositary Shares Rep 10 Ordinary Shares
FEDU
$19.9M
| $949K | ﹤0.01% |
29,656
| – | – |
|
2302
Liberty Global Class C
LBTYK
$3.27B
| $945K | ﹤0.01% |
43,355
-2,028
| -4% | -$45.6K |
|
2303
StoneX
SNEX
$8.85B
| $945K | ﹤0.01% |
97,959
+506
| +0.5% | +$4.19K |
|
2304
Arvinas
ARVN
$530M
| $941K | ﹤0.01% |
22,900
+6,400
| +39% | +$187K |
|
|
CUTR
2305
DELISTED
Cutera, Inc.
CUTR
| $940K | ﹤0.01% |
26,250
+150
| +0.6% | +$5.07K |
|
2306
nLIGHT
LASR
$3.82B
| $931K | ﹤0.01% |
45,900
| – | – |
|
2307
Tidewater
TDW
$3.91B
| $931K | ﹤0.01% |
48,300
-1,800
| -4% | -$28.7K |
|
2308
Sonic Automotive
SAH
$3.25B
| $928K | ﹤0.01% |
29,935
+150
| +0.5% | +$4.75K |
|
|
EB
2309
DELISTED
Eventbrite
EB
| $926K | ﹤0.01% |
45,900
| – | – |
|
|
SRNE
2310
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $924K | ﹤0.01% |
273,400
+100,000
| +58% | +$238K |
|
|
GOOD
2311
Gladstone Commercial Corp
GOOD
$627M
| $915K | ﹤0.01% |
41,870
+100
| +0.2% | +$2.27K |
|
2312
Surgery Partners
SGRY
$1.98B
| $914K | ﹤0.01% |
58,400
| – | – |
|
2313
Columbus McKinnon
CMCO
$472M
| $913K | ﹤0.01% |
22,800
| – | – |
|
2314
BGC Group
BGC
$5.65B
| $911K | ﹤0.01% |
153,290
+20,312
| +15% | +$115K |
|
|
AMAG
2315
DELISTED
AMAG Pharmaceuticals
AMAG
| $911K | ﹤0.01% |
74,853
-10,400
| -12% | -$114K |
|
2316
TechTarget
TTGT
$275M
| $907K | ﹤0.01% |
34,770
+200
| +0.6% | +$5.08K |
|
|
PDLI
2317
DELISTED
PDL BioPharma, Inc.
PDLI
| $903K | ﹤0.01% |
278,222
| – | – |
|
2318
Atara Biotherapeutics
ATRA
$69.5M
| $900K | ﹤0.01% |
2,186
| – | – |
|
|
HT
2319
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
| $899K | ﹤0.01% |
61,760
-3,980
| -6% | -$56.4K |
|
|
AAWW
2320
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $899K | ﹤0.01% |
32,622
-1,099,872
| -97% | -$27.5M |
|
2321
Veeco
VECO
$2.96B
| $896K | ﹤0.01% |
61,012
+320
| +0.5% | +$4.36K |
|
2322
ANI Pharmaceuticals
ANIP
$1.78B
| $894K | ﹤0.01% |
14,500
+50
| +0.3% | +$3.31K |
|
2323
Grupo Aval
AVAL
$5.72B
| $894K | ﹤0.01% |
102,530
| – | – |
|
2324
Astronics
ATRO
$3.47B
| $893K | ﹤0.01% |
38,352
+960
| +3% | +$23.6K |
|
2325
Buckle
BKE
$2.25B
| $892K | ﹤0.01% |
33,002
-1,907
| -5% | -$45.3K |
|
Similar funds
AllianceBernstein's Q4 2019 Portfolio in Review
As of Q4 2019, AllianceBernstein held 3,209 positions worth $176B, up 9.6% from $161B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Trading was light in Q4 2019: portfolio turnover was 4.6%. AllianceBernstein opened 57 new positions and exited 91, leaving the 3,209-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- AllianceBernstein's largest Q4 2019 buy was Tradeweb Markets: 1,191,306 shares worth $55.2M.
- AllianceBernstein added most to Nike in Q4 2019, an estimated $392M increase.
- AllianceBernstein's biggest Q4 2019 reduction was JPMorgan Chase, cutting an estimated $341M.
- AllianceBernstein fully exited Celgene Corp in Q4 2019, selling an estimated $194M.
- AllianceBernstein's ten largest holdings make up 19% of its $176B portfolio in Q4 2019.
- AllianceBernstein opened 57 new positions and closed 91 in Q4 2019.
- AllianceBernstein's portfolio value rose 9.6% quarter-over-quarter to $176B.
Based on AllianceBernstein's 13F filing for Q4 2019, filed 18 Feb 2020.